A case of ciliary body mesectodermal leiomyoma with rapid growth and loss of vision necessitating enucleation.
Ciliary body
Histopathology
Mesectodermal leiomyoma
Tumor
Journal
Annals of medicine and surgery (2012)
ISSN: 2049-0801
Titre abrégé: Ann Med Surg (Lond)
Pays: England
ID NLM: 101616869
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
16
11
2020
revised:
22
11
2020
accepted:
23
11
2020
entrez:
11
12
2020
pubmed:
12
12
2020
medline:
12
12
2020
Statut:
epublish
Résumé
Mesectodermal leiomyoma of the ciliary body is a benign rare tumor that rarely presents acutely with a complicated clinical course. We are reporting a 39-year-old healthy female who presented with subacute blurred vision in her right eye secondary to a ciliary body mass. Initial fine needle aspiration biopsy ruled out a melanoma but the patient meanwhile experienced rapid complicated growth of the mass with vision loss, for which her right globe was eventually enucleated. The tumor was diagnosed histopathologically to be mesectodermal leiomyoma. The clinical course of our case was unique because of the subacute onset of her symptoms, the rapid growth of her benign tumor, and the complicated tumor behaviour leading to enucleation. An acute presentation of mesectodermal leiomyoma has been reported only once among similar cases in the recent literature. The tumor in our case showed the characteristic histopathological and immunohistochemical findings described before. Ophthalmologists should be aware of the unusual acute/subacute presentation of a rather benign lesion. Delayed diagnosis may result in ophthalmic complications and loss of the globe.
Identifiants
pubmed: 33304581
doi: 10.1016/j.amsu.2020.11.067
pii: S2049-0801(20)30494-5
pmc: PMC7718211
doi:
Types de publication
Case Reports
Langues
eng
Pagination
651-653Informations de copyright
© 2020 The Authors.
Déclaration de conflit d'intérêts
This case report was prepared in accordance with the ethical standards and the Helsinki Declaration. No trial of new drugs or therapy is applicable in this case. Case reports do not require Ethical approval in our institution. A general written informed consent was taken from the patient, which includes permission for anonymous use of information and photos for reporting. The authors have no conflict of interest to declare in relation to this case report. This manuscript was not submitted to any other journal.
Références
Int J Surg. 2018 Dec;60:132-136
pubmed: 30342279
Cancer. 1977 May;39(5):2102-13
pubmed: 870167
J Korean Med Sci. 2003 Aug;18(4):614-7
pubmed: 12923346
Eye (Lond). 2013 May;27(5):669-72
pubmed: 23519275
Ocul Oncol Pathol. 2017 Nov;3(4):304-309
pubmed: 29344486